Skip to main content

Table 1 Laboratory findings on admission

From: Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report

WBC 4800 /μl AST 27 U/l C3 100 mg/dl
Neutrophil 33 % ALT 20 U/l C4 19 mg/dl
Lymphocyte 58 % LDH 296 U/l CH50 45 U/ml
Hb 13.1 g/dl CK 91 U/l ANA 1:80  
PLTs 23.3 /μl Aldorase 9.9 IU/L    
ESR 7 mm/hr CRP 0.1 mg/dl anti-SAE Ab positive (IP-WB)
    KL-6 646 U/ml anti-NXP2 Ab negative (IP-WB)
PT (INR) 0.93   ferritin 33 mg/ml anti-MDA5 Ab negative (NR < 32 titer index, EIA)
APTT 32.8 sec IgG 1287 mg/dl anti-ARS Ab negative (NR < 25, titer index, EIA)
FDP 1.0 μg/ml IgA 133 mg/dl anti-TIF1 Ab negative (NR < 32, titer index, EIA)
D-dimer 0.9 μg/ml IgM 87 mg/dl anti-Mi-2 Ab negative (NR < 53 titer index, EIA)
  1. Abbreviation: Ab autoantibodies, ALT alanine aminotransferase, ANA antinuclear antibody, APTT activated partial thromboplastin time, ARS aminoacyl tRNA synthetase, AST aspartate aminotransferase, CH50 complement hemolytic activity, CK creatine kinase, CRP C-reactive protein, C3 complement component 3, C4 complement component 4, EIA enzyme immunoassay, ESR erythrocyte sedimentation rate, FDP fibrin degradation products, Hb hemoglobin, IgA immunoglobrin A, IgG immunoglobrin G, IgM immunoglobrin M, IP-WB immunoprecipitation Western blotting, KL-6 Krebs von den Lungen-6, LDH lactate dehydrogenase, MDA5 melanoma differentiation-associated gene 5, NR normal range, NXP2 nuclear matrix protein 2, PLTs platelets, PT (INR) prothrombin time (international normalized ratio), SAE small ubiquitin-like modifier activating enzyme, TIF1 transcriptional intermediary factor 1, WBC white blood count